Company news
Sihuan Pharmaceutical Holdings Group Ltd. news in 2026
Sihuan Pharmaceutical Holdings Group Ltd.'s news releases, calls and decks from 2026, newest first.
Voluntary announcement share repurchase
November 19, 2026
Next Day Disclosure Return
November 19, 2026
Voluntary announcement - new indication of xuanzhu biopharm's Bireociclib included in the 2026 NRDL
November 16, 2026
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2026
November 2, 2026
Voluntary announcement- phase III clinical study data of xuanzhu biopharm's Anaprazole Sodium for reflux esophagitis presented at UEG Week 2026
October 21, 2026
Voluntary announcement - polycaprolactone microsphere facial filler for Injection and hyaluronic acid sodium composite solution for Injection independently developed by meiyan space, a subsidiary of Sihuan Pharmaceutical, approved for market launch in hong kong
October 20, 2026
Voluntary announcement-Sihuan Pharmaceutical completed a strategic investment in canton biologics to enhance the layout of the entire industrial chain of regenerative medical aesthetics
October 8, 2026
Voluntary announcement - new specifications of skin booster (brand name: dongyan) of Sihuan Pharmaceutical approved for launch by nmpa
October 5, 2026
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2026
October 2, 2026
Notification Letter and Request Form to Non-registered Holder
September 16, 2026
Notification Letter and Change Request Form to Registered Shareholder
September 16, 2026
Interim Report 2026
September 16, 2026